
Jaguar Uranium Corp. Class A
JAGUAMEXEnergyUranium
Previous close
$1.55
−$0.05 · -3.13%
JAGU company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Sell
Trim exposure — unfavorable risk-reward
Valuation
28
Expensive
Momentum
20
Strong Down
Sentiment
59
Mixed
Risk resilience
34
High Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteJaguar Uranium Corp. is primarily involved in securing and advancing mineral properties across Latin America, with a central focus on discovering and developing uranium deposits. Its main exploration undertaking is the Berlin Project, encompassing approximately 9,053 hectares in Colombia. Additionally, the company holds interests in two other ventures: the extensive Laguna Project, which covers roughly 230,000 hectares of exploration claims in the central part of Argentina's Chubut Province, and the Huemul Project, comprising about 27,700 hectares of exploration claims located in the southern region of Mendoza Province, Argentina. Jaguar Uranium Corp. was established in 2022 and its corporate headquarters are situated in Thornhill, Canada.
- Industry
- Uranium
- Sector
- Energy
- Headquarters
- CA
- CEO
- Steven Gold
- Listed since
- Feb 10, 2026
- Employees
- 3
Market position
Day range
Current $1.55
52-week range
Current $1.55
- Open
- $1.60
- Previous close
- $1.60
- Volume
- 108.94K
- 0.9× average
- Average volume
- 121.4K
- Average daily volume
- Market cap
- 31.3M USD
- Beta
- -0.86
- Market reference 1
- 50-day average
- $1.7252
- -10.16% below average
- 200-day average
- $2.1124
- -26.62% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 35.45M USD
- EV / EBITDA
- -15.36×
- Earnings yield
- -6.54%
- Free cash flow yield
- -2.67%
Profitability & efficiency
- Return on equity
- -39.46%
- Return on assets
- -27.65%
- Return on invested capital
- -31.43%
Financial health
- Current ratio
- 0.19×
Financial statements
Income trends
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Cost of goods sold | — | 2.52K USD | — |
| Gross profit | — | −2.52K USD | — |
| Selling, general, and administrative | 2.05M USD | 2.22M USD | 97.73K USD |
| Operating expenses | 2.33M USD | 3.72M USD | 97.73K USD |
| Interest income | — | 370.22K USD | 174 USD |
| Interest expense | 941 USD | — | — |
| Depreciation and amortization | 5.48K USD | 3.45K USD | — |
| Operating income | −2.33M USD | −3.72M USD | −97.73K USD |
| Net income | −2.31M USD | −5.76M USD | −91.63K USD |
Company facts updated Aug 24, 2026.
Earnings
- Latest fiscal-year EPS
- -0.26
- FY2025
- Latest fiscal-year revenue
- 0 USD
- FY2025
Annual EPS trend
Reported history and fiscal-year consensus
Annual revenue trend
Reported history and fiscal-year consensus
JAGU peers
ETFs holding JAGU
Funds reporting this stock among their holdings, ordered by reported position size.
Continue in GoAI
Research JAGUresearch.disclaimer






